Acute Leukemia after Infliximab Therapy [6]

American Journal of Gastroenterology

Volumn 98, Issue 11, 2003, Pages 2577-

  Alcaín, Guillermo ^a   Andrade, Raúl J ^a,b   Queipo De Llano, María P ^a   Moreno, María J ^a   García Cortés, Miren ^a   Franquelo, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; ETANERCEPT; INFLIXIMAB; MESALAZINE; METHOTREXATE; RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANAMNESIS; ANOREXIA; ASTHENIA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL TRIAL; CROHN DISEASE; DIAGNOSTIC PROCEDURE; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG SAFETY; FISTULA; GASTROINTESTINAL SYMPTOM; HUMAN; LABORATORY TEST; LETTER; LYMPHOMA; MALAISE; NEOPLASM; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0344064951     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(03)01715-5     Document Type: Letter

References (7)

1. Brown SL, Greene MH, Gershon SK, et al. Tumor necrosis factor antagonist therapy and lymphoma development: Twenty six cases reported to the Food and Drug Administration. Arthritis Rheum 2002;46:3151-8.
2. Cohen RB, Dittrich KA. Anti-TNF therapy and malignancy - a critical review. Can J Gastroenterol 2001;15:277-84.
3. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial. Lancet 2002;359:1541-9.
4. Murase T, Hotta T, Saito H, Ohno R. Effect of recombinant human tumour necrosis factor on the colony growth of human leukemia progenitor cells and normal haematopoietic progenitor cells. Blood 1987;69:467-72.
5. Zhou M, Findley HW, Ma L, et al. Effect of tumor necrosis factor-α on the proliferation of leukemic cells from children with B-cell precursor-acute lymphoblastic leukemia (BCP-ALL): Studies of primary leukemic cells and BCP-ALL cell lines. Blood 1991;77:2002-7.
6. + myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-κB activation. J Immunol 1999;163:3106-15.
7. Biernaux BC, Loos M, Sels A, et al. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 1995;86:3118-22.